Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04950049
Other study ID # Zhangyonghai02
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 15, 2021
Est. completion date August 31, 2021

Study information

Verified date June 2021
Source General Hospital of Ningxia Medical University
Contact Hanxiang Ma
Phone +86-13519591508
Email mahanxiang@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the efficacy of dilution with glucose and prolonged injection time on dexamethasone 21-phosphate induced perineal irritation (include pian and pruritus).


Description:

Dexamethasone is a synthetic glucocorticoid, which may cause perineal irritation when given intravenously. The major clinical manifestations are pruritus and pain,and the incidence vary between 38%-71%. Some patients undergo spontaneous remission, while others develop into severe pain or pruritus. In clinical practice, dexamethasone is always diluted with glucose in many cases, but diluted dexamethasone in relieving dexamethasone induced perineal irritation has not been studied yet. The aim of this study was to investigate the efficacy of dilution with glucose on dexamethasone induced perineal irritation.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date August 31, 2021
Est. primary completion date August 31, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Aged 18-65 years - ASA physical status I-II Exclusion Criteria: - On regular use of analgesic - Contraindication or allergy to steroid or glucose - Drug or alcohol abuse - Diagnosed with paresthesia or mental diseases - Communication disorders - Pregnancy or nursing

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Dexamethasone
receive 2ml dexamethasone (5mg/ml)
Other:
Diluted dexamethasone 5ml
receive 5ml dexamethasone (2mg/ml) diluted with 5% glucose
Diluted dexamethasone 10ml
receive 10ml dexamethasone (1mg/ml) diluted with 5% glucose
Diluted dexamethasone 20ml
receive 20ml dexamethasone (0.5mg/ml) diluted with 5% glucose

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
General Hospital of Ningxia Medical University

Outcome

Type Measure Description Time frame Safety issue
Primary The incidence of dexamethasone-induced perineal irritation The investigators record the number of cases of dexamethasone-induced perineal irritation (pain or pruritus) and calculate the incidence During the first 3 min period after the injection of dexamethasone
Secondary Duration of perineal irritation If perineal irritation occurs, the investigators will record its duration After the injection of dexamethasone, up to 5 minutes
Secondary The severity of perineal irritation If perineal irritation occurs, the investigators will assess its severity by using Visual Analogue Scale (the minimum is 0 and the maximum is 10, and the higher scores mean a worse outcome) After the injection of dexamethasone, up to 5 minutes
See also
  Status Clinical Trial Phase
Completed NCT05035888 - Prophylactic Norepinephrine and Phenylephrine Boluses for Postspinal Anesthesia Hypotension N/A
Completed NCT04028791 - Sickle Cell Trait and Exercise, Effect of Hot Environment N/A
Completed NCT04556357 - Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia N/A
Completed NCT04118322 - The Effect of Peppermint Oil on Nausea, Vomiting and Retching in Cancer Patients Undergoing Chemotherapy N/A
Recruiting NCT03456544 - Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China
Completed NCT03723109 - Airway Management During TCI vs RSI Anesthesia Induction
Completed NCT03316417 - Study of Adverse Renal Effects of Immune Checkpoints Inhibitors
Completed NCT05712018 - Comparison of Different HES Coload Volumes on the 90% ED of Norepinephrine N/A
Not yet recruiting NCT04576663 - Phenylephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia N/A
Completed NCT03006042 - Pharmacokinetics of BPV Following Bilateral US-guided TAP Block for C-section N/A
Completed NCT03011775 - Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease Phase 4
Completed NCT04556370 - Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia. N/A
Completed NCT03706755 - Comparison of Two Doses of Norepinephrine in Preventing Hypotension After Spinal Anesthesia Phase 4
Completed NCT02854787 - Intravenous Bolus of Phenylephrine vs. Norepinephrine in Preventing Hypotension After Spinal Anesthesia Phase 4
Completed NCT02768168 - The Effects of Dezocine Pretreatment on Dexamethasone Induced Perineal Irritation N/A
Completed NCT04272567 - Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension N/A
Recruiting NCT05310331 - Donafenib for Recurrent Cervical Cancer Phase 2
Completed NCT05690334 - Different Crystalloid Coload Volumes on the 90% ED of Norepinephrine N/A
Completed NCT05475873 - Ondansetron for Postspinal Anesthesia Hypotension N/A
Recruiting NCT03220919 - Efficacy and Safety of Weight-Based Insulin Titration Regimen in Hospitalized Patients With Type 2 Diabetes N/A